Richard Daniell

Executive Vice President, European Commercial

Richard Daniell became Executive Vice President, European Commercial in November 2017, leading all activities of Teva Europe’s Generic, Specialty and over the counter (OTC) businesses as well as our Teva API and Medis B2B units.

With headquarters in The Netherlands, Teva Europe employs approximately 19,000 people in the region and covers 36 countries. Teva is Europe’s biggest provider of tried-and-trusted generic medicine, a leading provider of OTC medicines and a recognized innovator in CNS, respiratory medicines and biopharmaceuticals.

Before assuming this responsibility, Richard headed up Teva Europe Generics. Prior to that he served as Chief Operating Officer of International Markets and led the integration of the Actavis Generics business into Teva globally. Before that he served as General Manager for the United Kingdom and Ireland.

Richard received his B.Sc. degree in chemistry from the University of Auckland, New Zealand.


Kåre Schultz

President and Chief Executive Officer, Member of the Board of Directors

Read more
Dr. Sven Dethlefs

Dr. Sven Dethlefs

Executive Vice President, North America Commercial

Read more

Eric Drapé

Executive Vice President, Global Operations

Read more

Dr. Hafrun Fridriksdottir

Executive Vice President, Global R&D

Read more
Galia Inbar

Galia Inbar

Executive Vice President, Chief Human Resources Officer and Head of Global Communications and Brand

Read more

Eli Kalif

Executive Vice President, Chief Financial Officer (CFO)

Read more

Mark Sabag

Executive Vice President, International Markets Commercial

Read more
Eli Shani

Eli Shani

Executive Vice President, Global Marketing and Portfolio

Read more
David M. Stark

David M. Stark

Executive Vice President, Chief Legal Officer

Read more

Nir Baron

Senior Vice President, Chief Internal Auditor

Read more

Lori Queisser

Sr. Vice President & Global Compliance Officer

Read more